52 related articles for article (PubMed ID: 38609388)
21. JNK Pathway in CNS Pathologies.
de Los Reyes Corrales T; Losada-Pérez M; Casas-Tintó S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918666
[TBL] [Abstract][Full Text] [Related]
22. Brain DNA Methylation Patterns in CLDN5 Associated With Cognitive Decline.
Hüls A; Robins C; Conneely KN; Edgar R; De Jager PL; Bennett DA; Wingo AP; Epstein MP; Wingo TS
Biol Psychiatry; 2022 Feb; 91(4):389-398. PubMed ID: 33838873
[TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
[TBL] [Abstract][Full Text] [Related]
24. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.
Guo T; Zhang D; Zeng Y; Huang TY; Xu H; Zhao Y
Mol Neurodegener; 2020 Jul; 15(1):40. PubMed ID: 32677986
[TBL] [Abstract][Full Text] [Related]
25. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation.
Niu J; Tsai HH; Hoi KK; Huang N; Yu G; Kim K; Baranzini SE; Xiao L; Chan JR; Fancy SPJ
Nat Neurosci; 2019 May; 22(5):709-718. PubMed ID: 30988524
[TBL] [Abstract][Full Text] [Related]
26. Blood-Brain Barrier: From Physiology to Disease and Back.
Sweeney MD; Zhao Z; Montagne A; Nelson AR; Zlokovic BV
Physiol Rev; 2019 Jan; 99(1):21-78. PubMed ID: 30280653
[TBL] [Abstract][Full Text] [Related]
27. The crystal structure of DR6 in complex with the amyloid precursor protein provides insight into death receptor activation.
Xu K; Olsen O; Tzvetkova-Robev D; Tessier-Lavigne M; Nikolov DB
Genes Dev; 2015 Apr; 29(8):785-90. PubMed ID: 25838500
[TBL] [Abstract][Full Text] [Related]
28. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
Winkler EA; Nishida Y; Sagare AP; Rege SV; Bell RD; Perlmutter D; Sengillo JD; Hillman S; Kong P; Nelson AR; Sullivan JS; Zhao Z; Meiselman HJ; Wendy RB; Soto J; Abel ED; Makshanoff J; Zuniga E; De Vivo DC; Zlokovic BV
Nat Neurosci; 2015 Apr; 18(4):521-530. PubMed ID: 25730668
[TBL] [Abstract][Full Text] [Related]
29. Beta amyloid-induced upregulation of death receptor 6 accelerates the toxic effect of N-terminal fragment of amyloid precursor protein.
Xu Y; Wang D; Luo Y; Li W; Shan Y; Tan X; Zhu C
Neurobiol Aging; 2015 Jan; 36(1):157-68. PubMed ID: 25150572
[TBL] [Abstract][Full Text] [Related]
30. A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.
Kallop DY; Meilandt WJ; Gogineni A; Easley-Neal C; Wu T; Jubb AM; Yaylaoglu M; Shamloo M; Tessier-Lavigne M; Scearce-Levie K; Weimer RM
J Neurosci; 2014 May; 34(19):6425-37. PubMed ID: 24806669
[TBL] [Abstract][Full Text] [Related]
31. A DR6/p75(NTR) complex is responsible for β-amyloid-induced cortical neuron death.
Hu Y; Lee X; Shao Z; Apicco D; Huang G; Gong BJ; Pepinsky RB; Mi S
Cell Death Dis; 2013 Apr; 4(4):e579. PubMed ID: 23559013
[TBL] [Abstract][Full Text] [Related]
32. Death receptors DR6 and TROY regulate brain vascular development.
Tam SJ; Richmond DL; Kaminker JS; Modrusan Z; Martin-McNulty B; Cao TC; Weimer RM; Carano RA; van Bruggen N; Watts RJ
Dev Cell; 2012 Feb; 22(2):403-17. PubMed ID: 22340501
[TBL] [Abstract][Full Text] [Related]
33. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.
Nikolaev A; McLaughlin T; O'Leary DD; Tessier-Lavigne M
Nature; 2009 Feb; 457(7232):981-9. PubMed ID: 19225519
[TBL] [Abstract][Full Text] [Related]
34. Endothelial DR6 in blood-brain barrier malfunction in Alzheimer's disease.
Huang X; Qi J; Su Y; Zhou Y; Wang Q; Huang T; Xue D; Zeng Y; Verkhratsky A; Zhou B; Chen H; Yi C
Cell Death Dis; 2024 Apr; 15(4):258. PubMed ID: 38609388
[TBL] [Abstract][Full Text] [Related]
35. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
36. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
Liu L; Wan W; Xia S; Kalionis B; Li Y
Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
[TBL] [Abstract][Full Text] [Related]
37. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
38. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
39. Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.
Chaves JCS; Dando SJ; White AR; Oikari LE
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166967. PubMed ID: 38008230
[TBL] [Abstract][Full Text] [Related]
40. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
